Malaria is caused by a parasite, not by bacteria. The culprits are single-celled organisms belonging to the genus Plasmodium, which are classified as protozoan parasites and are about as distantly related to bacteria as you are to a mushroom.1PubMed Central. Plasmodium-a brief introduction to the parasites causing human malaria and their basic biology The confusion is understandable, though, because certain antibiotics do have antimalarial effects, and bacterial infections often tag along with malaria in ways that muddy the clinical picture.
What Plasmodium Actually Is
Bacteria are relatively simple organisms without a true nucleus. Plasmodium parasites are eukaryotes, meaning their cells contain a nucleus and other complex internal structures, much like your own cells do. They belong to a group called Apicomplexa, a phylum of parasites named for a specialized cluster of structures at one end of the cell that helps them invade host cells. Other members of this group include the parasites that cause toxoplasmosis and cryptosporidiosis. Plasmodium is obligately parasitic: it cannot survive or reproduce outside a host. It needs both a mosquito and a vertebrate to complete its life cycle, shuttling between the two in different developmental forms.
One unusual feature of Plasmodium is that it carries a remnant organelle called the apicoplast, which evolved from an ancient photosynthetic ancestor. The parasite shares certain metabolic pathways with plants but has lost many of them over evolutionary time. Its genome retains the ability to make only about half of the standard amino acids on its own.2Trends in Parasitology. Nutrient acquisition and metabolism by Plasmodium liver-stage parasites This reliance on the host for nutrients is part of what makes Plasmodium a parasite rather than a free-living organism. The apicoplast, as we’ll see later, also explains why some antibiotics happen to work against malaria.
Five Species, One Disease Name
When people say “malaria,” they’re actually talking about disease caused by any of at least five Plasmodium species that regularly infect humans. Four have been recognized for a long time: P. falciparum, P. vivax, P. ovale, and P. malariae. A fifth, P. knowlesi, is a monkey malaria parasite that has increasingly been jumping to humans in Southeast Asia and is now considered the fifth human malaria species.3PubMed Central. Biology of human malaria plasmodia including Plasmodium knowlesi Each species differs in how long its replication cycle takes inside red blood cells, how severe the disease tends to be, and whether it can hide in the liver for months or years.
P. falciparum is the deadliest of the group and is responsible for the vast majority of malaria deaths worldwide, particularly in sub-Saharan Africa.4PubMed Central. Unlocking the potential of novel RTS, S/AS01, and R21/Matrix‐M™ malaria vaccines in African nations It can infect red blood cells of all ages, leading to extremely high parasite loads, and it causes infected red blood cells to stick to the walls of small blood vessels. When this happens in the brain, it produces cerebral malaria, one of the most dangerous complications.5PubMed Central. Cerebral Plasmodium falciparum malaria: The role of PfEMP1 in its pathogenesis and immunity, and PfEMP1-based vaccines to prevent it P. vivax, the most geographically widespread species, is less immediately lethal but has a trick that makes it especially hard to eliminate: it can go dormant in the liver and reactivate months or years later.
How Plasmodium Gets Into Your Body
The parasite is transmitted exclusively by female Anopheles mosquitoes. When an infected mosquito bites you, it injects saliva to keep your blood flowing, and mixed in with that saliva are Plasmodium sporozoites, the infectious stage of the parasite.6PubMed Central. Malaria: influence of Anopheles mosquito saliva on Plasmodium infection These sporozoites are deposited into your skin, where they need to find and enter a blood vessel so they can travel to the liver.7PubMed Central. Revisiting the Plasmodium sporozoite inoculum and elucidating the efficiency with which malaria parasites progress through the mosquito
This is worth pausing on, because people often think of the mosquito as the “cause” of malaria. Mosquitoes are the vector, the delivery vehicle, but they are not the pathogen. The distinction matters practically: killing mosquitoes, using bed nets, and applying repellent all reduce transmission, but they do not treat the infection once you have it. For that, you need drugs that target the parasite itself. This vector-versus-cause confusion shows up consistently in surveys of communities in malaria-endemic regions, where people frequently identify the mosquito as the cause of malaria rather than the organism the mosquito carries.8PubMed Central. Knowledge and Misconceptions about Malaria among Pregnant Women in a Post-Conflict Internally Displaced Persons’ Camps in Gulu District, Northern Uganda
The Two-Stage Journey Inside You
Once sporozoites reach the liver, they invade liver cells and begin multiplying silently. You feel nothing during this stage, which lasts roughly a week or two depending on the species. Each infected liver cell eventually bursts, releasing thousands of a new parasite form called merozoites into the bloodstream. These merozoites invade red blood cells, and this is where the disease actually begins.
Inside each red blood cell, the parasite feeds, grows, and divides. When the new parasites are ready, they rupture the red blood cell and spill out to invade fresh ones. This cycle of invasion, multiplication, and rupture repeats every 24 to 72 hours depending on the species, and the synchronized bursting of large numbers of red blood cells is what triggers malaria’s characteristic periodic fevers.9PubMed. The Challenge of Quantifying Synchrony in Malaria Parasites The older medical literature described “tertian” fevers (every 48 hours) and “quartan” fevers (every 72 hours) based on which species was responsible, though in practice fevers are not always this neat, especially with P. falciparum.
The destruction of red blood cells is what produces most of malaria’s symptoms: anemia from the loss of red cells, the release of parasite waste products that provoke inflammation, and in severe cases, organ damage from infected cells clogging small blood vessels. None of this is caused by a toxin the way some bacterial infections work. The damage comes from the parasite physically occupying and destroying your cells and from your own immune response to the debris.
The Dormant Liver Stage That Complicates Everything
Two species, P. vivax and P. ovale, have an additional trick that no bacterium uses in quite the same way. Some of the sporozoites that enter liver cells don’t immediately start multiplying. Instead, they go dormant, forming what are called hypnozoites, tiny sleeping forms that can sit in the liver for weeks, months, or even years before suddenly waking up and launching a new wave of blood-stage infection.10PubMed Central. Plasmodium vivax latent liver infection is characterized by persistent hypnozoites, hypnozoite-derived schizonts, and time-dependent efficacy of primaquine This is called a relapse, and it’s one of the biggest obstacles to eliminating vivax malaria globally.11PubMed. Azithromycin disrupts apicoplast biogenesis in replicating and dormant liver stages of the relapsing malaria parasites Plasmodium vivax and Plasmodium cynomolgi
Hypnozoites are metabolically very quiet. Studies in a closely related species, P. cynomolgi, which is used as a lab model, found that dormant hypnozoites activate only about a third of the metabolic pathways that replicating liver-stage parasites use.12PubMed Central. A comparative transcriptomic analysis of replicating and dormant liver stages of the relapsing malaria parasite Plasmodium cynomolgi That low profile makes them hard to detect and hard to kill. Standard antimalarial drugs that target the blood stage don’t touch hypnozoites. Only a handful of drugs, primarily primaquine and tafenoquine, can clear them, and both carry a risk of serious side effects in people with a common enzyme deficiency.
Why Some Antibiotics Work Against a Parasite
This is probably the single biggest reason people wonder whether malaria might be bacterial. Doctors sometimes prescribe doxycycline, a tetracycline antibiotic, both to prevent and to treat malaria. If malaria is caused by a parasite, why would an antibiotic help?
The answer lies in that plant-derived organelle mentioned earlier, the apicoplast. The apicoplast has its own small genome and its own protein-making machinery, and that machinery looks a lot like what bacteria use. This isn’t a coincidence: the apicoplast descended from an ancient bacterium that was engulfed by a predecessor of the Plasmodium lineage over a billion years ago. Because the apicoplast’s ribosomes still resemble bacterial ribosomes, antibiotics designed to block bacterial protein production can also jam the apicoplast’s machinery.13PubMed Central. Anti-malarial Drug Design by Targeting Apicoplasts: New Perspectives – Section: Drugs targeting apicoplast translation machinery
The catch is that these antibiotics kill Plasmodium much more slowly than they kill actual bacteria. When the apicoplast is disrupted, the parasite doesn’t die immediately. Instead, it completes its current replication cycle and only fails during the next one, a phenomenon researchers call “delayed death.”14Biochemical Society Transactions. Targeting the apicoplast in malaria This is why doxycycline is usually combined with a faster-acting antimalarial for treatment, or used alone only for prevention, where the slower kill speed doesn’t matter because the drug is already in your system when parasites arrive.
Doxycycline’s antimalarial action may actually be more complex than simple ribosome blocking. Research has found evidence that doxycycline can also interfere with iron availability inside the apicoplast, disrupting essential processes that the organelle needs to function.15eLife. Doxycycline has distinct apicoplast-specific mechanisms of antimalarial activity So even among the “antibiotics that happen to work on malaria,” the mechanisms are not a simple copy of what those drugs do to bacteria. The parasite is a fundamentally different organism being hit in a borrowed weak spot.
When Malaria and Bacteria Actually Do Show Up Together
Another reason the bacteria-or-parasite question persists is that real bacterial infections frequently accompany malaria, especially in tropical regions where both are common. A large systematic review found that among patients with both malaria and a bacterial bloodstream infection, the most frequent combination involved P. falciparum and gram-negative bacteria, with Salmonella species being the most common bacterial partner.16PubMed Central. The Prevalence of Malaria and Bacteremia Co-Infections among Febrile Patients: A Systematic Review and Meta-Analysis There’s evidence that malaria itself may make people more vulnerable to bacterial infections by suppressing parts of the immune system and damaging the gut lining, giving bacteria a route into the blood.
The co-infection picture looks different depending on the setting. In a study of Vietnamese adults hospitalized with severe falciparum malaria, only about 1% had a concurrent bacterial bloodstream infection, but those who did had a death rate roughly three times higher than patients with malaria alone.17Clinical Infectious Diseases. Concomitant Bacteremia in Adults With Severe Falciparum Malaria Among travelers returning to non-endemic countries with malaria, bacterial co-infections appear to be even rarer, with one study finding clinically relevant bacteria in only about 0.3% of blood cultures.18PubMed Central. Bacterial coinfections in travelers with malaria: rationale for antibiotic therapy The practical takeaway is that while malaria itself is not bacterial, clinicians in endemic areas have to think about bacterial infections as a simultaneous possibility, particularly in severely ill patients.
Persistent Misconceptions About What Causes Malaria
Surveys in malaria-endemic communities repeatedly turn up a cluster of beliefs that are close to the truth but miss the mark. The most common is the one already mentioned: that mosquitoes themselves cause malaria, rather than acting as carriers of a parasite. In one study of pregnant women in northern Uganda, the vast majority identified mosquitoes as the cause, but almost none mentioned the Plasmodium parasite. Other reported “causes” included cold food, playing in the rain, cold weather, and eating mangoes.8PubMed Central. Knowledge and Misconceptions about Malaria among Pregnant Women in a Post-Conflict Internally Displaced Persons’ Camps in Gulu District, Northern Uganda
These misconceptions aren’t trivial. If you believe cold weather causes malaria, you might focus on staying warm rather than sleeping under a treated bed net. If you believe the mosquito bite itself is the disease rather than the parasite it carries, you might not finish a full course of antimalarial treatment because you think the problem ended when the bite healed. Public health campaigns have had to grapple with the fact that even partial understanding, knowing mosquitoes are involved, can lead to incomplete protective behavior when the parasite’s role isn’t understood.
How the Discovery Unfolded
For most of human history, malaria was attributed to “bad air” (the name comes from the Italian mala aria), swamp gases, or supernatural causes. The breakthrough came in 1880, when a French military doctor named Alphonse Laveran looked at blood from a malaria patient under a microscope and saw the parasites directly. It took another 18 years before Italian researchers, including Giovanni Battista Grassi and his colleagues, demonstrated conclusively that the parasites were transmitted by Anopheles mosquitoes.19PubMed Central. History of the discovery of the malaria parasites and their vectors This timeline matters because germ theory was still relatively new in the 1880s, and many researchers initially suspected a bacterium was responsible. Laveran’s discovery that the pathogen was a protozoan, not a bacterium, was met with skepticism for years before the evidence became overwhelming.
Drug Resistance and the Parasite’s Adaptability
Malaria parasites, particularly P. falciparum, have repeatedly evolved resistance to the drugs used against them. Chloroquine resistance emerged decades ago and made what was once a cheap, reliable treatment useless in much of the world. The current front-line drugs are artemisinin-based combination therapies, and resistance to artemisinins is already spreading, particularly in Southeast Asia.
The mechanism behind artemisinin resistance illustrates just how sophisticated this parasite is. Artemisinins work by generating toxic protein damage inside the parasite. Resistant strains, often carrying a mutation in a gene called Kelch13, appear to counteract this by ramping up their ability to manage damaged proteins, essentially beefing up the cellular recycling system so the parasite can survive the drug’s assault.20PubMed Central. Mechanisms of artemisinin resistance in Plasmodium falciparum malaria Research has linked this to the parasite’s autophagy pathway, a kind of internal cleanup crew. In field samples, the Kelch13 resistance mutation co-occurs with a mutation in an autophagy-related protein over 85% of the time, suggesting the two work together.21PubMed Central. Autophagy Underlies the Proteostasis Mechanisms of Artemisinin Resistance in P. falciparum Malaria This kind of coordinated genetic adaptation is characteristic of a complex eukaryotic organism, not a simple bacterium, and it makes the fight against malaria a moving target.
Bacteria That Fight the Parasite Inside Mosquitoes
In an ironic twist, some of the most promising new approaches to malaria control involve using actual bacteria against the parasite. The microbiome of the mosquito, the community of bacteria living in its gut, turns out to influence whether Plasmodium can successfully develop inside the mosquito and be transmitted to humans.22PubMed Central. Malaria and the Microbiome: A Systematic Review
Researchers have identified a naturally occurring bacterium, Delftia tsuruhatensis TC1, isolated from mosquitoes that were unable to support Plasmodium development. This bacterium colonizes the mosquito gut, produces a small molecule called harmane that inhibits early stages of parasite development, and doesn’t appear to harm the mosquito itself.23PubMed. Delftia tsuruhatensis TC1 symbiont suppresses malaria transmission by anopheline mosquitoes Another gut bacterium, a strain of Serratia marcescens, achieves a similar anti-parasite effect through a different route: it activates the mosquito’s own immune system to fight off the parasite.24PubMed Central. A Gut Symbiotic Bacterium Serratia marcescens Renders Mosquito Resistance to Plasmodium Infection Through Activation of Mosquito Immune Responses
The appeal of these approaches is that they could potentially be deployed without genetic modification of the mosquitoes, sidestepping some of the regulatory and ecological concerns around gene drives. Whether they can work at the scale needed to put a dent in malaria transmission is still an open question, but the research illustrates an interesting biological reality: in the war against malaria, bacteria are potential allies against the parasite, not the enemy themselves.
How Malaria Has Shaped Human Genetics
Malaria has been killing humans for so long that it has left a visible imprint on our genome. Across malaria-endemic regions, natural selection has favored genetic variations that offer some protection against severe disease, even when those same variants carry health costs of their own.25PubMed Central. Human genetic variations conferring resistance to malaria The most famous example is sickle cell trait: carrying one copy of the sickle hemoglobin gene provides substantial protection against falciparum malaria, while carrying two copies causes sickle cell disease. Other protective variants affect red blood cell surface proteins, enzymes, and hemoglobin structure, and they are concentrated in populations with long histories of malaria exposure.
This evolutionary legacy is one more piece of evidence that the relationship between humans and Plasmodium is ancient and intimate in a way that bacterial infections rarely are. Bacteria evolve fast and can cause devastating epidemics, but few single bacterial pathogens have exerted the kind of sustained, continent-wide selective pressure on the human genome that Plasmodium has. The parasite has been shaping us, and we’ve been shaping it, for hundreds of thousands of years.